Featured Research

from universities, journals, and other organizations

Chemists Discover New Way Antioxidants Fight Debilitating Diseases

Date:
August 22, 2007
Source:
Clemson University
Summary:
Debilitating diseases are often linked to DNA damage that occurs when metal ions in the body produce reactive oxygen compounds that damage cells. Studies have shown antioxidants that neutralize this activity and are found in fruits, vegetables, green tea, garlic and onions can be effective at preventing damage. Scientists have now found a new mechanism for antioxidant activity: antioxidants bind to naturally present iron and copper to prevent formation of compounds that damage DNA.

Cancer, cardiovascular diseases, Parkinson's and Alzheimer's are often linked to DNA damage that occurs when metal ions in the body such as iron and copper produce reactive oxygen compounds that damage human cells. Studies have shown antioxidants that neutralize this activity and that occur naturally in fruits, vegetables, green tea, garlic and onions can be effective at preventing DNA damage.

A Clemson team of chemists, presenting its research at the 234th annual American Chemical Society national meeting in Boston Aug. 19-24, has found a new mechanism for antioxidant activity: the antioxidants bind to naturally present iron and copper in the body to prevent formation of reactive oxygen compounds that damage DNA.

"Our studies have shown that antioxidants even at low concentrations found in these foods bind to iron and copper and prevent DNA damage," said lead investigator and chemist Julia Brumaghim. "This goes a long way in understanding how antioxidant supplements might help treat or even prevent these debilitating illnesses."

The group is now testing its findings in bacterial cells and will test human cells next.

Clemson graduate students on the project include Erin E. Battin, Nathan R. Perron and Ria R. Ramoutar. Research is funded through a grant from the American Heart Association.


Story Source:

The above story is based on materials provided by Clemson University. Note: Materials may be edited for content and length.


Cite This Page:

Clemson University. "Chemists Discover New Way Antioxidants Fight Debilitating Diseases." ScienceDaily. ScienceDaily, 22 August 2007. <www.sciencedaily.com/releases/2007/08/070819133751.htm>.
Clemson University. (2007, August 22). Chemists Discover New Way Antioxidants Fight Debilitating Diseases. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2007/08/070819133751.htm
Clemson University. "Chemists Discover New Way Antioxidants Fight Debilitating Diseases." ScienceDaily. www.sciencedaily.com/releases/2007/08/070819133751.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins